Manabu Akazawa
Overview
Explore the profile of Manabu Akazawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goto R, Inose R, Shoji T, Akazawa M, Muraki Y
J Infect Chemother
. 2025 Feb;
31(3):102657.
PMID: 39938650
Background: Antimicrobial resistance is a major global threat, and the promotion of antimicrobial stewardship (AS) is critical. Although AS is recognized for its economic benefits, the situation in Japan has...
2.
Shinohara A, Takumoto Y, Tauchi J, Morishita K, Kawasaki T, Akazawa M
Sci Rep
. 2025 Jan;
15(1):267.
PMID: 39747263
We compared the cost-effectiveness of gemcitabine plus nab-paclitaxel (GnP) and modified FOLFIRINOX (mFFX)-standard first-line treatments for metastatic pancreatic cancer in Japan. This retrospective cohort study included patients with metastatic pancreatic...
3.
Shoji T, Akazawa M, Inoue O, Suzuki T
J Infect Chemother
. 2024 Dec;
31(3):102586.
PMID: 39672325
Introduction: The incidence of syphilis is increasing in Japan. A new treatment, penicillin intramuscular injection, was launched in January 2022. This study aimed to determine syphilis treatments in Japan and...
4.
Sasahara Y, Takumoto Y, Watanabe K, Takeda H, Umemoto K, Sunakawa Y, et al.
Front Health Serv
. 2024 Jul;
4:1275496.
PMID: 39071080
Background: Quality-of-life (QOL) is important for cancer patients with poor prognosis. However, conducting a QOL survey with patients is difficult. Therefore, we conducted a QOL survey with physicians. Specifically, this...
5.
Okada Y, Inada K, Akazawa M
J Clin Psychopharmacol
. 2024 Apr;
44(3):263-271.
PMID: 38684048
Background: We compared the effectiveness of long-acting injectable antipsychotics (LAIs) and oral antipsychotics (OAs) in treating schizophrenia, focusing on whether the benefits of LAIs over OAs are evident even in...
6.
Akazawa M, Sato T, Ebata N, LoPresti M, Nishi R
Patient Prefer Adherence
. 2024 Mar;
18:607-622.
PMID: 38476590
Background: About one-third of caregivers of pediatric or adolescent growth hormone deficiency (pGHD) patients in Japan have reported poor treatment adherence. However, few studies have examined factors related to adherence...
7.
Kimura Y, Suzukawa M, Inoue N, Imai S, Horiguchi H, Akazawa M, et al.
Asian Pac J Allergy Immunol
. 2024 Jan;
PMID: 38183647
Background: Selecting optimal biologics based on type 2 biomarkers has been of interest in severe asthma treatment. However, few direct biomarker stratification-based comparisons have been made. Objective: To compare the...
8.
Murakami S, Akazawa M, Honda H
Infect Control Hosp Epidemiol
. 2023 Nov;
45(4):459-466.
PMID: 37937440
Objective: The days of therapy (DOT) metric, used to estimate antimicrobial consumption, has some limitations. Days of antibiotic spectrum coverage (DASC), a novel metric, overcomes these limitations. We examined the...
9.
Takumoto Y, Shibahara R, Asami H, Akazawa M
Cancer Med
. 2023 May;
12(13):14742-14755.
PMID: 37199073
Background: This study aimed to clarify the treatment patterns of pancreatic cancer patients receiving systemic chemotherapy in Japan and to estimate the direct medical costs in actual practice. Research Design...
10.
Okada Y, Inada K, Akazawa M
Schizophr Res
. 2023 Jan;
252:300-308.
PMID: 36706475
Objective: To compare the effectiveness of different long-acting injectable antipsychotics (LAIs) (aripiprazole, paliperidone, risperidone, and fluphenazine/haloperidol) in patients with schizophrenia in Japan. Methods: We conducted a retrospective cohort study using...